Inactive Instrument

Insiders Altimmune Inc Nyse

Equities

End-of-day quote Nyse Other stock markets
- ^USD	-

Apr. 02	Transcript : Altimmune, Inc. - Special Call
Mar. 27	Altimmune Shares Slip Wednesday, After Reporting a Wider Q4 Net Loss and Dropping Prospective Treatment for Hepatitis B	MT

Altimmune, Inc. Appoints Catherine Angell Sohn, Pharm.D. to Its Board of Directors	23-03-27	CI
Altimmune, Inc. Appoints Raymond Jordt as Chief Business Officer	23-01-04	CI
Insider Sell: Altimmune	22-12-22	MT
Insider Sell: Altimmune	22-09-01	MT
Insider Sell: Altimmune	22-07-05	MT
Insider Sell: Altimmune	22-06-28	MT
Altimmune, Inc. Announces Management Changes	21-12-13	CI
Altimmune Names Richard Eisenstadt as Next CFO	21-12-13	MT
ObsEva Names Will Brown Chief Financial Officer	21-12-13	MT
ObsEva to Appoint Altimmune CFO to Same Position	21-12-13	MT
Insider Trends: Altimmune Insider Disposition Interrupting 90-Day Buy Trend	20-12-02	MT
Insider Trends: 90-Day Insider Buying Trend at Altimmune Interrupted with Disposition of Shares	20-11-13	MT
Insider Trends: Insider Disposition at Altimmune Scaling Back 90-Days of Buying	20-11-13	MT
Altimmune, Inc. Announces Board Changes	20-07-16	CI
Altimmune, Inc. Appoints Diane Jorkasky to Its Board of Directors	20-05-12	CI
Altimmune, Inc. Appoints M. Scott Harris as Chief Medical Officer	19-09-09	CI
Altimmune, Inc. Announces Appointment of William Brown as Chief Financial Officer	19-06-12	CI
Altimmune, Inc. Announces Resignation of Sybil Tasker as Chief Medical Officer, Effective June 30, 2019	19-06-07	CI
Altimmune, Inc. Announces Executive Changes	18-11-27	CI
Altimmune, Inc. Announces Management Changes	18-10-22	CI

No results for this search